Edit and publish insight
Signal headline
Decision / action required
Owner → function
Deadline
Priority
Action
QC workflow: Draft → Under QC review (team notified) → Published. AI-generated insights are always saved as draft first. Use "Send for QC review" to flag for team sign-off before publishing.
Change detail
Add market
1
Welcome
Platform tour
4 decisions need action this week
2 urgent (revenue model + Germany BIA). 1 market contraction watch (UK COVID-19). 1 evidence gap (France flu). RSV and Paediatric Influenza are the highest-priority therapy areas.
2
Urgent
2
Watch
1
Positive
9
Markets
Decisions Requiring Attention This Week
Your Pipeline — Current Status
What You Need To Do
Asset-specific actions this week
Decision Timeline
Upcoming inflection points across all markets
This week: 6 signals across 4 therapy areas. 2 need your attention now.
Sorted by portfolio impact. Use filters to focus on what matters to you.
Filter:
Showing all 6
| Market | Therapy area | Body | Cohort (as defined by NITAG committee) | Current recommendation | Revaccination schedule (= forecast commercial impact) | Next meeting / decision | Source |
|---|
Agenda confirmed
Agenda pending
Past
Quick prompts
Active scan sources
Health security, AMR & specialist media sources
Non-NITAG sources for AMR guidance, specialist regulatory media, and disease surveillance. Toggle on/off individually. Click the external link icon to verify the URL is live before activating scan.
Other public sources
Specialist pharmaceutical trade press and peer-reviewed vaccine intelligence. Filtered to platform scope (NITAG decisions, immunization recommendations, regulatory and HTA actions, AMR signals). Irrelevant general-news items are excluded.
Therapy areas in scope
Scan schedule
Frequency
Video ingestionYouTube and stream transcripts enabled
LanguagesEN · DE · FR · IT · ES · JA · ZH
TranslationMachine + human QA
Last scan4 May 2026 09:41 — 6 new items
Active scan coverage
Loading…